Insider Transactions in Q3 2024 at Puma Biotechnology, Inc. (PBYI)
Insider Transaction List (Q3 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 12
2024
|
Michael Patrick Miller Director |
SELL
Open market or private sale
|
Direct |
23,358
-33.2%
|
$70,074
$3.49 P/Share
|
|
Jul 17
2024
|
Maximo F Nougues Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
4,156
-2.49%
|
$12,468
$3.7 P/Share
|
|
Jul 17
2024
|
Jeffrey Jerome Ludwig Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
2,598
-2.15%
|
$7,794
$3.7 P/Share
|
|
Jul 17
2024
|
Douglas M Hunt Officer |
SELL
Open market or private sale
|
Direct |
3,637
-2.66%
|
$10,911
$3.7 P/Share
|
|
Jul 17
2024
|
Alan H Auerbach President and CEO |
SELL
Open market or private sale
|
Direct |
21,920
-0.31%
|
$65,760
$3.7 P/Share
|
|
Jul 02
2024
|
Maximo F Nougues Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,295
-3.08%
|
$15,885
$3.27 P/Share
|
|
Jul 02
2024
|
Douglas M Hunt Officer |
SELL
Open market or private sale
|
Direct |
4,349
-3.08%
|
$13,047
$3.27 P/Share
|
|
Jul 02
2024
|
Jeffrey Jerome Ludwig Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
6,051
-4.76%
|
$18,153
$3.27 P/Share
|
|
Jul 02
2024
|
Alan H Auerbach President and CEO |
SELL
Open market or private sale
|
Direct |
18,885
-0.27%
|
$56,655
$3.27 P/Share
|